Sara Zalba Oteiza

Sara Zalba Oteiza serves as a Researcher within the Department of Pharmaceutical Sciences at the Faculty of Pharmacy and Nutrition, University of Navarra, focusing exclusively on pharmaceutical research activities.

Education Background:

• PhD in Pharmaceutical Sciences, University of Navarra (2013). Dissertation: "Design and in-vitro/in-vivo evaluation in colon cancer cells of targeted oxaliplatin liposomes to epidermal growth factor receptor by conjugation of different ligands" under supervision of Dr. Maria Jesus Garrido Cid.

Research Specialization:

Her work centers on advanced drug delivery mechanisms for oncology applications, particularly EGFR-targeted liposomal systems for colon cancer chemotherapy. This integrates nanomedicine principles with pharmacological optimization to enhance oxaliplatin efficacy while reducing systemic toxicity. Core competencies span pharmaceutical formulation, in-vitro/in-vivo cancer models, and receptor-targeted therapeutic design within pharmaceutical oncology.

No institutional records indicate active grants, student supervision, or scientific awards. Her research operations occur within the university's Pharmaceutical Sciences infrastructure without dedicated lab branding or external funding disclosures in available documentation.